Advanced Accele. Ads (AAAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AAAP | NAMS | CNTA | ||
| Company | Advanced Accele. Ads | Newamsterdam Pharma Company N.V. | Centessa Pharmaceuticals Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 81.63 | 35.29 | 24.94 | ||
| High | 82.05 | 37.76 | 25.63 | ||
| Low | 81.50 | 34.95 | 24.88 | ||
| Latest | 81.63 | 35.76 | 25.04 | ||
| Change | +0.13 | +0.52 | +0.10 | ||
| % Change | +0.16% | +1.48% | +0.40% | ||
| Volume | 12,100 | 853,300 | 830,700 | ||
| 20-Day Average Volume | 103,245 | 597,895 | 1,513,920 | ||
| Previous Close | 81.50 | 35.24 | 24.94 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 81.69 | 33.50 | 24.59 | ||
| 20-Day Raw Stochastic | 60.92% | 72.45% | 61.50% | ||
| 20-Day Relative Strength | 55.42 | 56.07 | 53.53 | ||
| Weighted Alpha | +126.00 | +104.09 | +31.87 | ||
| Today's Opinion | N/A | 56% Buy | 56% Buy | ||
| Previous Opinion | N/A | 56% Buy | 72% Buy | ||
| Last Month's Opinion | N/A | 24% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.84% since 02/02/18 | +2.49% since 02/10/26 | +6.33% since 02/10/26 | ||
| Low | 80.64 on 02/05/18 | 33.14 on 02/11/26 | 22.50 on 02/11/26 | ||
| High | 82.05 on 02/09/18 | 37.76 on 02/18/26 | 25.80 on 02/13/26 | ||
| 1-Month | |||||
| %Chg | -0.21% since 01/09/18 | +12.99% since 01/16/26 | +12.79% since 01/16/26 | ||
| Low | 79.90 on 02/01/18 | 30.17 on 01/20/26 | 21.50 on 01/20/26 | ||
| High | 82.74 on 01/22/18 | 37.76 on 02/18/26 | 26.63 on 01/26/26 | ||
| 3-Month | |||||
| %Chg | +0.78% since 11/09/17 | -8.10% since 11/18/25 | -11.71% since 11/18/25 | ||
| Low | 79.90 on 02/01/18 | 30.17 on 01/20/26 | 21.50 on 01/20/26 | ||
| High | 82.74 on 01/22/18 | 42.00 on 11/26/25 | 30.58 on 12/08/25 | ||
| 6-Month | |||||
| %Chg | +63.26% since 08/09/17 | +40.79% since 08/18/25 | +42.35% since 08/18/25 | ||
| Low | 44.57 on 08/31/17 | 23.05 on 09/15/25 | 15.01 on 09/03/25 | ||
| High | 82.74 on 01/22/18 | 42.00 on 11/26/25 | 30.58 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,590,087 | 4,054,862 | 3,365,902 | ||
| Shares Outstanding, K | 43,980 | 113,391 | 134,421 | ||
| Annual Sales | 120,980,000 | 45,560,000 | 0 | ||
| Annual Net Income | -27,990,000 | -241,600,000 | -235,760,000 | ||
| Last Quarter Sales | 43,770,000 | 350,000 | 0 | ||
| Last Quarter Net Income | -26,730,000 | -72,010,000 | -50,340,000 | ||
| 60-Month Beta | 0.61 | 0.06 | 1.56 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.41 on 11/05/25 | -0.41 on 11/05/25 | ||
| Latest Earnings Date | 01/01/70 | 02/25/26 | 03/23/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||